Obesity causes insulin resistance by increasing activation of the sympathetic nervous system and the release of the stress hormone norepinephrine, according to a new study.
HealthDay on MSN3h
Mixed Link Seen for Gestational Exposure to Flame-Retardant Chemicals and Childhood ObesityThe association between gestational organophosphate ester (OPE) exposure and obesity in childhood is mixed, according to a ...
The RESPOND trial adapted to COVID-19 disruptions by shifting to a cluster-parallel randomized design, enabling analysis ...
"Our study found vitamin D supplementation may decrease blood pressure in specific subgroups such older people, people with ...
Vitamin D supplements may lower blood pressure in older people with obesity and taking more than the Institutes of Medicine's (IOM) recommended daily dose does not provide additional health benefits, ...
The majority of strokes could be prevented, according to new guidelines aimed at helping people and their doctors do just ...
Yet, in a 2021 review of nearly 700 obesity-related policies in England, researchers at the University of Cambridge found no ...
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...
GLP-1 receptor agonists, originally developed for managing type 2 diabetes, have rapidly emerged as highly effective ...
8h
Robert F. Kennedy Jr. has vowed to combat "the chronic disease epidemic in this country" in the Trump administration, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback